Dan Stanton

Dan Stanton is a B2B journalist in the biomanufacturing space, currently working as editorial expert at Sartorius.

Visible particulates in cell therapy: Industry looks toward a more realistic standard
Wednesday, April 15, 2026
The cell therapy sector remains constrained by particulate guidance based on traditional parenteral products, says a BioPhorum publication.